Skip to content
20-F

Annual Report (Foreign)

Baird Medical Investment Holdings Ltd BDMD BDMDW

0001104659-26-048641

← back to feed
Filed
Apr 24, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 27.79M sh
Shares Diluted restated FY 2025 · Dec 31, 2024 21.83M sh
Shares Diluted restated FY 2025 · Dec 31, 2023 20.59M sh
Shares Outstanding FY 2025 · Dec 31, 2025 40.98M sh
Capex FY 2025 · Dec 31, 2025 $42.32K
Capex FY 2025 · Dec 31, 2024 $2.85M
Capex FY 2025 · Dec 31, 2023 $2.64M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$1.34M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$6.31M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$1.02M
Long Term Debt FY 2025 · Dec 31, 2025 $6.09M
Long Term Debt FY 2025 · Dec 31, 2024 $3.44M
Short Term Debt FY 2025 · Dec 31, 2025 $2.64M
Short Term Debt FY 2025 · Dec 31, 2024 $867.77K
Cash And Equivalents FY 2025 · Dec 31, 2025 $178.32K
Cash And Equivalents FY 2025 · Dec 31, 2024 $2.97M
Stockholders Equity FY 2025 · Dec 31, 2025 $31.37M
Stockholders Equity FY 2025 · Dec 31, 2024 $39.66M
Current Liabilities FY 2025 · Dec 31, 2025 $32.36M
Current Liabilities FY 2025 · Dec 31, 2024 $34.62M
Total Liabilities FY 2025 · Dec 31, 2025 $38.48M
Total Liabilities FY 2025 · Dec 31, 2024 $38.2M
Current Assets FY 2025 · Dec 31, 2025 $54.97M
Current Assets FY 2025 · Dec 31, 2024 $61.42M
Total Assets FY 2025 · Dec 31, 2025 $69.7M
Total Assets FY 2025 · Dec 31, 2024 $77.96M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.98
Eps Diluted restated FY 2025 · Dec 31, 2024 $0.57
Eps Diluted restated FY 2025 · Dec 31, 2023 $0.51
Eps Basic FY 2025 · Dec 31, 2025 −$0.98
Eps Basic restated FY 2025 · Dec 31, 2024 $0.57
Eps Basic restated FY 2025 · Dec 31, 2023 $0.51
Sga Expense FY 2025 · Dec 31, 2025 $14.12M
Sga Expense FY 2025 · Dec 31, 2024 $7.1M
Sga Expense FY 2025 · Dec 31, 2023 $8.55M
Rd Expense FY 2025 · Dec 31, 2025 $20.13M
Rd Expense FY 2025 · Dec 31, 2024 $6.17M
Rd Expense FY 2025 · Dec 31, 2023 $4.27M
Net Income FY 2025 · Dec 31, 2025 −$27.28M
Net Income FY 2025 · Dec 31, 2024 $12.45M
Net Income FY 2025 · Dec 31, 2023 $10.55M
Operating Income FY 2025 · Dec 31, 2025 −$25.63M
Operating Income FY 2025 · Dec 31, 2024 $15.32M
Operating Income FY 2025 · Dec 31, 2023 $11.86M
Gross Profit FY 2025 · Dec 31, 2025 $18.88M
Gross Profit FY 2025 · Dec 31, 2024 $32.65M
Gross Profit FY 2025 · Dec 31, 2023 $27.23M
Cost Of Revenue FY 2025 · Dec 31, 2025 $3.65M
Cost Of Revenue FY 2025 · Dec 31, 2024 $4.38M
Cost Of Revenue FY 2025 · Dec 31, 2023 $4.23M
Revenue FY 2025 · Dec 31, 2025 $22.54M
Revenue FY 2025 · Dec 31, 2024 $37.04M
Revenue FY 2025 · Dec 31, 2023 $31.46M